Sign In
Buy ITCI
$131.87
+0 (+0%)
At Close: Jul 01, 2025
Study focuses on driving bacteria to produce potential antibiotic, antiparasitic compounds
01:54pm, Friday, 26'th Jun 2020
Researchers have developed a method to spur the production of new antibiotic or antiparasitic compounds hiding in the genomes of actinobacteria, which are the source of drugs such as actinomycin and s
ITI Ltd Q4 profit drops 47 pc to Rs 36.4 cr
01:26pm, Friday, 26'th Jun 2020
State-run electronics manufacturing firm ITI Ltd on Friday posted a 47 per cent drop in consolidated profit at Rs 36.46 crore for the March quarter on account of COVID-19 disrupting the supply chain
SGX Nifty up 55 points; here's what changed for market while you were sleeping
08:14am, Friday, 26'th Jun 2020
Nifty futures on the Singapore Exchange traded 57.5 points, or 0.56 per cent higher at 10,293.50, in signs that Dalal Street was headed for a positive start on Friday.
Stocks in the news: ITC, RIL, Vedanta, Ruchi Soya, Ashok Leyland and Coal India
07:39am, Friday, 26'th Jun 2020
Fitch Ratings upgraded RIL's long-term local-currency issuer default rating (IDR) to 'BBB+' from 'BBB',
Stocks in news: IRCTC, HAL, Ashok Leyland, CONCOR, Apollo Hospitals, Glenmark Pharma and more
03:06am, Friday, 26'th Jun 2020
Stocks to watch today on June 26: HAL, Ashok Leyland, CONCOR, Apollo Hospitals, IRCTC, Glenmark Pharma among others are the top stocks to watch out for in Friday's trading session.
IBM rolls out free digital learning platform to reach more job seekers, provide new resources to business owners
03:48pm, Thursday, 25'th Jun 2020
In November 2019, IBM India, in partnership with Directorate General of Training (DGT), Ministry of Skill Development and Entrepreneurship, Government of India, and its implementation partners, made t
Intra-Cellular Therapies (ITCI) Investor Presentation - Slideshow
11:13am, Thursday, 25'th Jun 2020
The following slide deck was published by Intra-Cellular Therapies, Inc. in conjunction with this event.
'Opportunity to Help Country': Hit By Covid-19 Lockdown, Locals Queue Up in Sikkim to Join Army
03:59am, Thursday, 25'th Jun 2020
The Army's job notification for 600 vacancies mentioned that those physically fit and in the 18-40 age group would be eligible to join as porters for a contract period of 179 days.
Intra-Cellular Therapies Target of Unusually Large Options Trading (NASDAQ:ITCI)
02:44am, Thursday, 25'th Jun 2020
Intra-Cellular Therapies Inc (NASDAQ:ITCI) was the target of some unusual options trading activity on Tuesday. Investors acquired 7,994 put options on the company. This represents an increase of 1,874
India to target import and use of smart power meters from China
12:46am, Thursday, 25'th Jun 2020
The move is part of a broad economic response to Chinese aggression along the border in Ladakh.EESL’s smart meter programme is aimed at replacing a total of 250 mn conventional meters
When you kept doubting the stocks rally, 32 BSE500 stocks doubled wealth in 3 months
12:33pm, Wednesday, 24'th Jun 2020
95% of BSE500 stocks from across sectors have delivered a positive returns since March 24.
India’s smart meter programme to shun Chinese manufacturers
11:42am, Wednesday, 24'th Jun 2020
NDA government plans to convert all electricity meters into smart prepaid meters by 2022
BNP Paribas Arbitrage SA Increases Stake in Intra-Cellular Therapies Inc (NASDAQ:ITCI)
07:04am, Wednesday, 24'th Jun 2020
BNP Paribas Arbitrage SA raised its stake in shares of Intra-Cellular Therapies Inc (NASDAQ:ITCI) by 173.2% in the first quarter, according to the company in its most recent 13F filing with the Securi
Intra-Cellular Therapies (NASDAQ:ITCI) Trading Up 0.4%
06:14am, Wednesday, 24'th Jun 2020
Intra-Cellular Therapies Inc (NASDAQ:ITCI) shares rose 0.4% on Monday . The company traded as high as $25.63 and last traded at $25.41, approximately 46,360 shares changed hands during mid-day trading
Do Hedge Funds Love Intra-Cellular Therapies Inc (ITCI)?
01:08am, Wednesday, 24'th Jun 2020
In this article you are going to find out whether hedge funds think Intra-Cellular Therapies Inc (NASDAQ:ITCI) is a good investment right now. We like to check what the smart money thinks first before
